Long Island Heart

State-of-the-art Cardiovascular Care for the clinician

Mark your calendar for October 29-30, 2021!

If you are not already on our email list, click here to be notified when registration opens for 2021.

Conference Collaborator:

EVENT INFORMATION

The live online event was held on November 6-7, 2020
On-Demand recordings of the conference are available until December 7th
Information for earning your CME credits will be available after you view the recordings
Upon registration, confirmation, and receipt of payment will be provided via email
Login information and instructions will be emailed to you

Registration

This event is currently closed for registration.

PROGRAM OVERVIEW

In the United States, cardiovascular diseases claim more lives than all forms of cancer combined. Currently more than one in three adults live with one or more types of cardiovascular disease. Long Island Heart: State-of-the-Art Cardiovascular Care for the Clinician is designed to provide clinicians with the best practices and state of the art advances in diagnostics and therapeutics for cardiovascular disease.

EDUCATIONAL Goal

Utilizing interactive lectures and case study presentations, the goal of this live online conference is to combine recent clinical trials and translational research with state of the art cardiovascular management to provide the practicing cardiovascular disease clinician with a comprehensive overview of cardiovascular disease management and the tools to integrate these strategies into their clinical practice.

TARGET AUDIENCE

Long Island Heart: State-of-the-Art Cardiovascular Care for the Clinician is intended for interventional cardiologists, clinical cardiologists, cardiothoracic surgeons, hospitalists, internists, family practitioners, pulmonologists, nephrologists, emergency medicine physicians, nurses, nurse practitioners, physician assistants, and clinicians who provide care for patients with cardiovascular disease.

LEARNING OBJECTIVES

Upon completion of this activity, participants will be better able to:

Review the current epidemiology, diagnosis, pathogenesis, and treatment of cardiovascular disease
Integrate the current and emerging diagnostic and pharmacologic therapies for cardiovascular disease into clinical practice
Review the strategies and challenges related to the management of cardiovascular disease
Discuss the impact of diagnostic and treatment strategies on patient outcomes in cardiovascular disease

REGISTRATION FEE

13.25 Credit Hours: $75.00

Registration Confirmation and Refund Policy:

Upon receipt of payment, your registration will be secured and a confirmation email will be provided. If requested, a full refund will be provided within 30 days of the conference.

DOWNLOAD AGENDA

COURSE DIRECTORS / PLANNING COMMITTEE

Hal A. Skopicki, MD, PhD
Ambassador Charles A . Gargano Chief of Cardiology
Co-Director, Stony Brook Heart Institute
Director, Heart Failure and Cardiomyopathy Program
Co-Director, Ventricular Assist Device (VAD) Program
Stony Brook Medicine
Stony Brook, NY

On Chen, MD
Assistant Professor
Department of Medicine
Stony Brook University School of Medicine
Interventional Cardiology
Director of Outpatient Cardiology
Director, Advanced Lipid Disorders Program
Stony Brook Medicine
Stony Brook, NY

Smadar Kort, MD, FACC, FASE, FAHA
Professor, Department of Medicine
Director, Valve Center
Stony Brook University School of Medicine
Director, Noninvasive Cardiac Imaging
Director, Echocardiography
Director of Interventional Echocardiography
Past Governor, American College of Cardiology, Downstate, New York
Stony Book Medicine
Stony Brook, NY

Robert T. Pyo, MD
Associate Professor, Department of Medicine
Stony Brook University School of Medicine
Director, Interventional Cardiology, Stony Brook Medicine
Director, Interventional Cardiology
Medical Director, Structural Heart Program
Stony Brook Medicine
Stony Brook, NY

SESSION MODERATORS:

Grace Chung, MD Division of Cardiology, Department of Medicine, Heart Associates of Long Island, Stony Brook University School of Medicine, Stony Brook, NY

John Savino III, MD Division of Cardiology, Department of Medicine, Heart Associates of Long Island, Stony Brook University School of Medicine, Stony Brook, NY

Trevor Verga, MD Division of Cardiology, Department of Medicine, North Suffolk Cardiology, Stony Brook University School of Medicine, Stony Brook, NY

Johnathan Weinstein, DO Division of Cardiology, Department of Medicine, North Suffolk Cardiology, Stony Brook University School of Medicine, Stony Brook, NY

Disclosure of Faculty Financial Interest or Relationships

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Complete disclosure of relevant (or no) financial relationships will be made to learners prior to the beginning of the CME activity.

ACCREDITED PROVIDER

This activity is jointly provided by Global Education Group and myMedEd, Inc.

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and myMedEd, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:
Global Education Group designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict Of Interest Disclosure Policy:
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accredited Provider Discosures:
Lindsay Borvansky has nothing to disclose.
Ashley Cann has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.

Disclosure Of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and myMedEd, inc do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Long Island Heart: State-of-the-Art Cardiovascular Care is designed to provide a comprehensive overview of cardiovascular disease, focusing on state-of-the-art diagnostics and therapeutics. Our faculty of national and international experts utilize interactive lectures, discussion panels and live questioning to assist you in integrating these strategies into your clinical practice.

Click on the links below to view the programs from years past.

4^th Annual Long Island Heart Conference - November 6-7, 2020

3^rd Annual Long Island Heart Conference - May 10-11, 2019

2^nd Annual Long Island Heart Conference - May 18-19, 2018

1^st Annual Long Island Heart Conference – May 19-20, 2017

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible:

Abbott
Abiomed
Actelion Pharmaceuticals US, Inc
Akcea Therapeutics
Alnylam Pharmaceuticals
Amarin Pharma, Inc.
Amgen, Inc.
Arbor Pharmaceuticals, LLC.
Astelllas Pharma US, Inc.
AstraZeneca
Biotel Heart
Biotronik, Inc.
Boehringer Ingelheim
- Pharmaceuticals, Inc.
Boston Scientific Corporation
Chiesi USA Inc.
Cumberland Pharmaceuticals
Edwards Lifesciences Corporation
GE Healthcare
GeneDx, Inc.
Gilead Sciences, Inc.

Heart Failure Society of America (HFSA)
Invitae
iRhythm Technologies, Inc.
Janssen Pharmaceuticals, Inc.
Kowa Pharmaceuticals America, Inc.
Lantheus Medical Imaging
Lundbeck Pharmaceuticals
Medtronic
New York State Chapter of the
- American College of Cardiology (NY-ACC)
Novartis Pharmaceuticals Corporation
Novo Nordisk, Inc.
Otsuka America Pharmaceutical, Inc.
Pfizer, Inc.
Portola Pharmaceuticals, Inc.
Preventice Solutions
Regeneron Pharmaceuticals, Inc.
Relypsa, Inc.
Stony Brook Heart Institute
Zoll Medical

Conference Collaborator:

Planned By myMedEd, Inc.

Accredited Provider:

Endorsements

Officially endorsed by the New York State Chapter of the American College of Cardiology and the Heart Failure Society of America. The opinions presented in this educational activity do not necessarily reflect the opinions or recommendations of the NY-ACC or the HFSA.